Question 1

What is Masato Murakami?

Accepted Answer

Masato Murakami is a Person.

Question 2

How often does Masato Murakami appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 6 articles.

Question 3

When was Masato Murakami first tracked by Ergen?

Accepted Answer

First tracked on Jun 11, 2026.

Question 4

When was Masato Murakami last mentioned in news?

Accepted Answer

Last active on Jun 11, 2026.

Question 5

What is Masato Murakami's current news sentiment?

Accepted Answer

Aggregate sentiment score: 60 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Masato Murakami in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving Masato Murakami?

Accepted Answer

Curium, PeptiDream complete prostate cancer trial (Jun 11, 2026, 6 articles).

Question 8

How did the "Curium, PeptiDream complete prostate cancer trial" event impact Masato Murakami?

Accepted Answer

Masato Murakami, President of PDRadiopharma and Executive Vice President of PeptiDream, expressed satisfaction with the completion of patient dosing, acknowledging the strong collaboration and its importance for prostate cancer patients in Japan.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.